Novel Technology Commercialization

Blazing a trail isn’t easy, but that’s not why you’re doing it. Navigating strategy for novel technologies and creating new, uncharted markets requires creativity, innovation, and experience. We’re here to help.

Our Experts

Stephane Budel

Miguel Edwards

Andrew Aijian

Carl Schoellhammer

Schedule a Call

Related Client Results

All Client Results

Clinical Diagnostics

Genetic Testing Company Assessment

A group asked DeciBio to identify and evaluate clinical genetic testing labs for potential acquisition

View

Target Identification

Clinical Diagnostics

New Prenatal Opportunity Assessment

A multinational pharmaceutical and diagnostics company was interested in learning more about the U.S. market opportunity for their novel noninvasive prenatal test in development

View

Voice-of-Customer Research

Go-to-Market Strategy

Pharma & Biotech

Clinical, Genomic, and Pathology Real-World Data (RWD) Market Landscape Assessment

A real-world data (RWD) provider wanted to identify key use cases, unmet needs, and future opportunities in the RWD market, with a particular focus on clinical, genomic, and pathology RWD and biopharma users.

View

Voice-of-Customer Research

Pricing Strategy

Competitive Analysis

Clinical Diagnostics

NIPT Market Landscape and Strategy

A large multi-national diagnostic company was interested in understanding the market landscape and potential strategy for the decentralization of NIPT in the U.S.

View

Voice-of-Customer Research

Competitive Analysis

Customer Segmentation

Go-to-Market Strategy

Research Tools

Cell Line Market 5-Year Forecast

A large life science tools provider was interested in characterizing the genome engineering and engineered cell line market to identify potential opportunities to participate in the space

View

Voice-of-Customer Research

Pharma & Biotech

Global Companion Diagnostic Guideline Mapping and Strategy

A large pharma new to precision oncology wanted to understand the processes and requirements to ensure that their novel CDx was included into diagnostic guidelines globally

View

Biomarker and Diagnostics Strategy

Go-to-Market Strategy

Precision Medicine is evolving at a rapid pace

Discover how we can help

Get in Touch